decaprenyl phosphate: required for membrane-derived oligosaccharide biosynthesis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 45479680 |
| CHEBI ID | 66867 |
| MeSH ID | M0187778 |
| Synonym |
|---|
| decaprenyl phosphate |
| C02970 |
| LMPR03020008 |
| 3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2z,6z,10z,14z,18z,22z,26z,30z,34e,38-decaen-1-yl phosphate |
| mono-trans, octa-cis decaprenyl-phosphate |
| CHEBI:66867 |
| omega-e-octa-z-decaprenyl phosphate |
| (2z,6z,10z,14z,18z,22z,26z,30z,34e)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl dihydrogen phosphate |
| Q27135479 |
| Class | Description |
|---|---|
| polyprenol phosphate | A prenol phosphate resulting from the formal condensation of the terminal allylic hydroxy group of a polyprenol with 1 mol eq. of phosphoric acid. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (10.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (90.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||